Santen Pharmaceutical Co., Ltd.
SNPHF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $93 | $95 | $58 | $83 |
| Short-Term Investments | $1 | $0 | $1 | $1 |
| Receivables | $72 | $91 | $107 | $100 |
| Inventory | $52 | $43 | $39 | $37 |
| Other Curr. Assets | $7 | $7 | $8 | $8 |
| Total Curr. Assets | $224 | $236 | $213 | $229 |
| Property Plant & Equip (Net) | $73 | $72 | $66 | $56 |
| Goodwill | $8 | $8 | $7 | $14 |
| Intangibles | $67 | $76 | $89 | $117 |
| Long-Term Investments | $27 | $24 | $37 | $41 |
| Tax Assets | $10 | $0 | $3 | $3 |
| Other NC Assets | $0 | $20 | $6 | $0 |
| Total NC Assets | $185 | $200 | $208 | $231 |
| Other Assets | -$0 | $0 | $0 | -$0 |
| Total Assets | $409 | $436 | $421 | $460 |
| Liabilities | – | – | – | – |
| Payables | $39 | $44 | $45 | $41 |
| Short-Term Debt | $3 | $3 | $3 | $14 |
| Tax Payable | $2 | $5 | $7 | $4 |
| Deferred Revenue | $0 | $0 | -$3 | -$14 |
| Other Curr. Liab. | $42 | $41 | $38 | $50 |
| Total Curr. Liab. | $87 | $93 | $90 | $96 |
| LT Debt | $0 | $0 | $28 | $13 |
| Deferred Rev, NC | $0 | $1 | -$28 | -$13 |
| Deferred Tax Liab, NC | $3 | $1 | $2 | $3 |
| Other NC Liab. | $35 | $35 | $37 | $25 |
| Total NC Liab. | $37 | $38 | $38 | $27 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $3 | $3 | $3 |
| Total Liabilities | $124 | $130 | $128 | $123 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $9 | $9 | $9 | $9 |
| Retained Earnings | $228 | $240 | $238 | $290 |
| AOCI | $41 | $48 | $38 | $30 |
| Other Equity | $9 | $9 | $9 | $9 |
| Total Equity | $286 | $306 | $294 | $337 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$1 | -$1 | -$1 | -$1 |
| Total Liab. & Tot. Equity | $409 | $436 | $422 | $461 |
| Net Debt | -$90 | -$92 | -$27 | -$56 |